Full Prescribing Information for Nutropin AQ
New Packaging and Device Information for Patients/Caregivers (98K/PDF)
New Packaging and Device Information for Healthcare Professionals (107K/PDF)
Read Patient/Parent Instructions (4.09MB/PDF)

The Nutropin AQ Pen® [somatropin (rDNA origin) injection] was developed to give patients the option of a delivery device that provides simplicity, convenience, and safety features. The simple design makes it easy to use and easy to teach while a one-step, dial-back dose knob makes it easy to correct over-dialing errors. The small and light design makes the Nutropin AQ Pen convenient to carry while the dose flash recall reminds patients of last dose administered.

The Nutropin AQ Pen has few steps to delivery reducing the chance of error and the needle shield-lock protects against needle contamination and damage. The Nutropin AQ Pen is for exclusive use with Nutropin AQ Pen Cartridges. Healthcare professionals should provide patient training prior to use.

Status Nutropin AQ Pen received U.S. Food and Drug Administration (FDA) clearance in April 2002. The Nutropin AQ Pen represents the first device approval for Genentech and is available in the U.S. by prescription only.